Stock Analysis on Net
Stock Analysis on Net

CVS Health Corp. (NYSE:CVS)

This company has been moved to the archive! The financial data has not been updated since May 1, 2025.

Return on Assets (ROA)
since 2005

Microsoft Excel

Calculation

CVS Health Corp., ROA, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-29), 10-K (reporting date: 2006-12-30), 10-K (reporting date: 2005-12-31).

1 US$ in millions


The financial performance from 2005 to 2024 reveals a significant structural shift in asset utilization and profitability. For the first twelve years of the period, Return on Assets (ROA) remained relatively stable, generally fluctuating between 4.82% and 8.01%, indicating a consistent ability to generate profit relative to the asset base.

Asset Base Expansion
Total assets experienced an exponential increase over the analyzed period, rising from US$ 15,283 million in 2005 to US$ 253,215 million by 2024. A pivotal expansion occurred between 2017 and 2018, where assets more than doubled from US$ 95,131 million to US$ 196,456 million, marking a fundamental change in the scale of the balance sheet.
Profitability and ROA Inflection
Net income grew steadily from 2005 until 2017, reaching US$ 6,622 million. However, 2018 represented a critical inflection point characterized by a net loss of US$ 594 million, which drove the ROA to a negative -0.30%. This period signifies the most substantial decline in operational efficiency within the observed timeframe.
Post-2018 Efficiency Trends
Following the 2018 contraction, profitability returned to positive territory, but ROA failed to recover to its historical pre-2018 levels. Between 2019 and 2024, ROA remained compressed, oscillating between 1.82% and 3.39%. Even as net income reached a peak of US$ 8,344 million in 2023, the expanded asset base resulted in a lower overall percentage return compared to the earlier, leaner operational phase.
Recent Performance Volatility
The final two years of the period show renewed volatility in profitability. The ROA decreased from 3.34% in 2023 to 1.82% in 2024, corresponding with a decline in net income from US$ 8,344 million to US$ 4,614 million, while total assets continued to climb to US$ 253,215 million.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Comparison to Competitors

CVS Health Corp., ROA, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-29), 10-K (reporting date: 2006-12-30), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Health Care Equipment & Services)

CVS Health Corp., ROA, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-29), 10-K (reporting date: 2006-12-30), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)

CVS Health Corp., ROA, long-term trends, comparison to industry (health care)

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-29), 10-K (reporting date: 2006-12-30), 10-K (reporting date: 2005-12-31).